Who can administer
  
                  May be administered by registered competent doctor or nurse/midwife
      
  
        Available preparations
  
                  Valoid 50mg per 1ml ampoule
      
  
        Reconstitution
  
                  Already in solution
Draw up using a 5 micron filter needle
      
  
        Infusion fluids
  
                  Not applicable - product ready for use
      
  
        Methods of intravenous administration
  
                  Slow intravenous injection
- Administer over at least 3 minutes (ref 1) as rapid intravenous injection can lead to symptoms similar to those of overdose
 
- It may be diluted with exactly 10ml Sodium chloride 0.9% or Glucose 5% to aid slow administration (ref 1)
 
- Immediately after dilution, and again just before administration, check the solution for signs of precipitation. Discard if there is any cloudiness or haze formation (unlicensed) (ref 1)
 
      
  
        Dose in adults
  
                  Usual dose
- Nausea and vomiting: 50mg, repeated up to three times daily
 
- Prevention of post-operative nausea: Give 50mg, 20 minutes before anticipated end of surgery
 
- Prevention of regurgitation and aspiration during emergency surgery: Give 25mg before induction of general anaesthesia
 
      
  
        Further information
  
                  
- Case reports of paralysis in patients using intravenous cyclizine - use with particular caution in patients with underlying neuromuscular disorders
 
- Cyclizine can have a hypotensive effect when given by the intravenous route
 
- Extravasation is likely to cause tissue damage due to its low pH (ref 1)
 
- Cyclizine is extremely irritant and can cause injection site reactions, including vein tracking, erythema, pain, rash, thrombophlebitis
(ref 1) 
- Blisters at the site of injection and pruritus, as well as sensation of heaviness, chills, agitation, flushing and hypotension have been reported with the IV route of administration
 
      
  
        Storage
  
                  Store below 250C
      
  
        References
  
                  SPC July 2018
1: Injectable Medicines administration guide, downloaded from Medusa 10/02/2025
      
  
        Therapeutic classification
  
                  Drug used in nausea and vertigo